- Home
- GNLX vs IHD Comparison
GNLX vs IHD Comparison
Compare GNLX & IHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- IHD
- Stock Information
- Founded
- GNLX 2001
- IHD 2011
- Country
- GNLX United States
- IHD United States
- Employees
- GNLX N/A
- IHD N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- IHD Investment Managers
- Sector
- GNLX Health Care
- IHD Finance
- Exchange
- GNLX Nasdaq
- IHD Nasdaq
- Market Cap
- GNLX 129.9M
- IHD 105.7M
- IPO Year
- GNLX 2023
- IHD N/A
- Fundamental
- Price
- GNLX $3.53
- IHD $5.93
- Analyst Decision
- GNLX Strong Buy
- IHD
- Analyst Count
- GNLX 5
- IHD 0
- Target Price
- GNLX $16.20
- IHD N/A
- AVG Volume (30 Days)
- GNLX 153.8K
- IHD 27.7K
- Earning Date
- GNLX 08-13-2025
- IHD 01-01-0001
- Dividend Yield
- GNLX N/A
- IHD 10.32%
- EPS Growth
- GNLX N/A
- IHD N/A
- EPS
- GNLX N/A
- IHD N/A
- Revenue
- GNLX N/A
- IHD N/A
- Revenue This Year
- GNLX N/A
- IHD N/A
- Revenue Next Year
- GNLX N/A
- IHD N/A
- P/E Ratio
- GNLX N/A
- IHD N/A
- Revenue Growth
- GNLX N/A
- IHD N/A
- 52 Week Low
- GNLX $1.60
- IHD $4.49
- 52 Week High
- GNLX $5.89
- IHD $5.47
- Technical
- Relative Strength Index (RSI)
- GNLX 58.36
- IHD 58.71
- Support Level
- GNLX $3.30
- IHD $5.89
- Resistance Level
- GNLX $3.60
- IHD $5.98
- Average True Range (ATR)
- GNLX 0.26
- IHD 0.05
- MACD
- GNLX 0.00
- IHD -0.01
- Stochastic Oscillator
- GNLX 75.71
- IHD 66.67
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About IHD Voya Emerging Markets High Income Dividend Equity Fund
Voya Emerging Markets High Dividend Equity Fund is a diversified closed-end management investment company. Its primary investment objective is to provide total return through a combination of current income, capital gains, and capital appreciation. The company seeks to achieve its investment objectives by investing principally in a portfolio of equity securities, and issuers in emerging market countries. The Fund will also normally seek to secure gains and enhance the stability of returns over a market cycle by writing (selling) call options on selected exchange-traded funds (ETFs) and/or international, regional, or country indices of equity securities, and/or on equity securities.